Table 5.
General characteristics of the study participants who were re-evaluated at the end of follow-up (n = 48).
| Baseline | Follow-Up | p | |
|---|---|---|---|
| Age | 71.0 ± 5.6 | 74.2 ± 5.8 | <0.0001 |
| BMI (kg/m2) | 27.7 ± 4.1 | 27.8 ± 4.2 | 0.689 |
| Total cholesterol (mg/dL) | 209.1 ± 49.9 | 198.5 ± 42. | 0.068 |
| HDL-C (mg/dL) | 50.6 ± 13.0 | 48.6 ± 12.0 | 0.089 |
| LDL-C (mg/dL) | 129.2 ± 500 | 120.9 ± 37.5 | 0.104 |
| Triglyceride (mg/dL) | 151.8 ± 62.9 | 149.5 ± 53.7 | 0.886 |
| SBP (mmHg) | 138.6 ± 15.4 | 136.4 ± 14.6 | 0.485 |
| DBP (mmHg) | 79.5 ± 8.1 | 77.2 ± 7.1 | 0.040 |
| GSM | 32.4 ± 10.5 | 32.1 ± 10.3 | 0.599 |
| NASCET score | 32.7 ± 12.6 | 37.6 ± 13.5 | <0.0001 |
| Creatinine (mg/dL) | 1.0 ± 0.2 | 1.0 ± 0.2 | 0.266 |
| eGFR (ml/min/1.73 m2) | 69.4 ± 17.3 | 67.2 ± 16.0 | 0.018 |
| SUA (mg/dL) | 5.6 ± 1.5 | 5.5 ± 1.2 | 0.770 |
| SUA/SCr ratio | 5.8 ± 1.9 | 5.6 ± 1.7 | 0.637 |
BMI: body mass index; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; SBP: systolic blood pressure; DBP: diastolic blood pressure; GSM: grayscale median; NASCET: North American Symptomatic Carotid Endarterectomy Trial; eGFR: estimated glomerular filtration rate; SUA: serum uric acid; SCr: serum creatinine.